Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spinach is a leading Canadian cannabis brand owned by Cronos Group, primarily serving the adult-use recreational market. The company offers a diverse portfolio of high-quality products, including dried flower, pre-rolls, vape cartridges, and edible gummies. Spinach is particularly recognized for its innovative SOURZ by Spinach gummy line and its Spinach Feelz products, which feature rare cannabinoids like cannabigerol (CBG). Leveraging the advanced R&D and fermentation capabilities of its parent company, Spinach focuses on delivering consistent, high-potency experiences through a farm-to-bowl philosophy. The brand maintains a significant retail presence across Canada and is a key driver of Cronos Group's domestic revenue. Its commitment to quality control and product differentiation has established it as a top-tier competitor in the Canadian cannabis landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spinach Cannabis.